BioMarin Pharmaceutical Inc. (BMRN)
Healthcare • Biotechnology
StockNasdaqGSUnited StatesUS09061G1013
56.88 USD
+0.32% today Updated 13 Nov 2026 16:49
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by BioMarin Pharmaceutical Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:49. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
22 Feb 2027
in 101 days · 16:00 · estimate 0.89
Last results
0.23 vs -0.11 estimated
02 Nov 2026 · Beat +304.8%
Beat the estimate
9 of 12
3 missed · 0 in line · 2 beats in a row
Average surprise
+34.8%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 22 Feb 2027 16:00 | 0.89 | — | — | Upcoming |
| 02 Nov 2026 16:00 | -0.11 | 0.23 | +304.8% | Beat |
| 06 Aug 2026 16:00 | 0.95 | 1.20 | +25.8% | Beat |
| 04 May 2026 16:00 | 0.91 | 0.76 | -16.9% | Miss |
| 23 Feb 2026 16:00 | 0.56 | 0.46 | -17.9% | Miss |
| 27 Oct 2025 16:00 | 0.34 | 0.12 | -64.3% | Miss |
| 04 Aug 2025 16:00 | 1.03 | 1.44 | +39.4% | Beat |
| 01 May 2025 16:00 | 0.95 | 1.13 | +18.6% | Beat |
| 19 Feb 2025 16:00 | 0.74 | 0.92 | +24.6% | Beat |
| 29 Oct 2024 16:00 | 0.79 | 0.91 | +14.7% | Beat |
| 05 Aug 2024 16:00 | 0.60 | 0.96 | +61.0% | Beat |
| 24 Apr 2024 16:00 | 0.60 | 0.71 | +18.3% | Beat |
| 22 Feb 2024 16:00 | 0.45 | 0.49 | +9.5% | Beat |
| 01 Nov 2023 16:00 | 0.48 | 0.46 | -4.7% | Miss |
| 31 Jul 2023 16:00 | 0.47 | 0.54 | +14.3% | Beat |
| 26 Apr 2023 16:00 | 0.40 | 0.60 | +48.5% | Beat |
| 27 Feb 2023 16:00 | 0.39 | 0.36 | -6.3% | Miss |
| 26 Oct 2022 16:00 | 0.43 | 0.45 | +4.9% | Beat |
| 03 Aug 2022 16:00 | 0.53 | 0.58 | +9.5% | Beat |
| 27 Apr 2022 16:00 | 0.46 | 0.54 | +18.8% | Beat |
| 23 Feb 2022 16:00 | -0.01 | 0.04 | +435.4% | Beat |
| 27 Oct 2021 16:00 | 0.09 | 0.18 | +105.0% | Beat |
| 28 Jul 2021 16:00 | 0.25 | 0.53 | +107.6% | Beat |
| 29 Apr 2021 16:00 | 0.30 | 0.57 | +86.8% | Beat |
| 25 Feb 2021 16:00 | 0.18 | 0.21 | +16.0% | Beat |
| 05 Nov 2020 16:00 | 0.26 | 0.50 | +95.7% | Beat |
| 04 Aug 2020 16:00 | 0.19 | 0.32 | +71.0% | Beat |
| 29 Apr 2020 17:00 | 0.33 | 0.62 | +86.3% | Beat |
| 26 Feb 2020 16:00 | 0.24 | 0.25 | +5.6% | Beat |
| 23 Oct 2019 16:00 | 0.34 | 0.42 | +23.2% | Beat |
| 01 Aug 2019 16:00 | 0.19 | 0.10 | -50.5% | Miss |
| 25 Apr 2019 16:00 | 0.10 | 0.14 | +35.7% | Beat |
| 21 Feb 2019 16:00 | 0.12 | -0.06 | -152.4% | Miss |
| 25 Oct 2018 16:00 | 0.15 | 0.34 | +128.5% | Beat |
| 02 Aug 2018 16:00 | 0.15 | 0.11 | -24.9% | Miss |
| 25 Apr 2018 16:00 | 0.13 | 0.12 | -3.7% | Miss |
| 22 Feb 2018 16:00 | 0.04 | 0.03 | -23.0% | Miss |
| 26 Oct 2017 16:00 | 0.08 | 0.04 | -40.8% | Miss |
| 02 Aug 2017 16:00 | 0.08 | 0.15 | +82.5% | Beat |
| 04 May 2017 16:00 | -0.01 | 0.20 | +1,766.7% | Beat |
| 23 Feb 2017 16:00 | -0.07 | -0.16 | -109.3% | Miss |
| 27 Oct 2016 16:00 | -0.08 | 0.02 | +121.3% | Beat |
| 04 Aug 2016 16:00 | -0.11 | 0.10 | +191.0% | Beat |
| 28 Apr 2016 16:00 | -0.28 | -0.16 | +44.0% | Beat |
| 25 Feb 2016 16:00 | -0.12 | -0.43 | -266.1% | Miss |
| 29 Oct 2015 16:00 | -0.58 | -0.56 | +3.4% | Beat |
| 03 Aug 2015 16:00 | -0.66 | -0.34 | +47.8% | Beat |
| 30 Apr 2015 16:00 | -0.56 | -0.39 | +30.4% | Beat |
| 25 Feb 2015 16:00 | -0.55 | -0.47 | +14.7% | Beat |
| 23 Oct 2014 16:00 | -0.24 | -0.32 | -29.4% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 3.2B | +12.9% | 348.9M | 10.8% | 1.80 | -18.6% | 717M |
| 2024 | 2.9B | +18.0% | 426.9M | 15.0% | 2.21 | +154.0% | 475.4M |
| 2023 | 2.4B | +15.4% | 167.6M | 6.9% | 0.87 | +16.0% | 51.6M |
| 2022 | 2.1B | — | 141.6M | 6.8% | 0.75 | — | 44.4M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 58.66 | 59.51 | 52.00 | 56.82 | -2.89% | 23,414,776 | |
| Oct 2026 | 59.81 | 60.16 | 53.90 | 58.51 | -2.48% | 54,919,600 | |
| Sep 2026 | 65.54 | 67.70 | 58.74 | 60.00 | -8.02% | 41,932,600 | |
| Aug 2026 | 60.43 | 70.98 | 58.89 | 65.23 | +8.68% | 47,340,800 | |
| Jul 2026 | 57.47 | 63.05 | 57.25 | 60.02 | +4.89% | 34,851,400 | |
| Jun 2026 | 56.55 | 59.77 | 53.01 | 57.22 | -0.12% | 46,395,700 | |
| May 2026 | 53.91 | 57.51 | 49.26 | 57.29 | +6.27% | 50,085,200 | |
| Apr 2026 | 56.72 | 57.76 | 52.46 | 53.91 | -4.57% | 32,463,600 | |
| Mar 2026 | 60.71 | 61.97 | 53.36 | 56.49 | -8.49% | 44,350,500 | |
| Feb 2026 | 56.40 | 66.28 | 56.26 | 61.73 | +9.18% | 46,227,600 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- BioMarin Pharmaceutical Hits $1 Billion Revenue Milestone, Advances Rare-Disease Pipeline (opens in a new tab) MarketBeat · 12 Nov 2026 01:12
- BioMarin Pharmaceutical Inc. (BMRN) Presents at Stifel 2026 Healthcare Conference 2026 Transcript (opens in a new tab) SeekingAlpha · 11 Nov 2026 19:48
- BioMarin Pharmaceutical Inc. 2026 Q3 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 05 Nov 2026 02:57
- JP Morgan Maintains Overweight on BioMarin Pharmaceutical, Lowers Price Target to $86 (opens in a new tab) Benzinga · 04 Nov 2026 16:11
- BioMarin to Participate in Upcoming Investor Conferences (opens in a new tab) 04 Nov 2026 14:00
- BioMarin: Better Risk-Reward Ahead Of Three FDA Decisions (opens in a new tab) SeekingAlpha · 04 Nov 2026 11:33
- BioMarin Pharmaceutical Inc (BMRN) Q3 2026 Earnings Call Highlights: First $1 Billion Revenue ... (opens in a new tab) GuruFocus.com · 04 Nov 2026 03:02
- BioMarin Pharmaceutical Inc. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 03 Nov 2026 13:30
- Morgan Stanley Maintains Overweight on BioMarin Pharmaceutical, Lowers Price Target to $119 (opens in a new tab) Benzinga · 03 Nov 2026 13:23
- Oppenheimer Maintains Outperform on BioMarin Pharmaceutical, Lowers Price Target to $94 (opens in a new tab) Benzinga · 03 Nov 2026 13:11
- HC Wainwright & Co. Reiterates Neutral on BioMarin Pharmaceutical, Maintains $60 Price Target (opens in a new tab) Benzinga · 03 Nov 2026 13:05
- BioMarin Beats Q3 Revenue Forecasts but Cuts 2026 Outlook on Voxzogo Timing and Deal Costs (opens in a new tab) InvestorsHub · 03 Nov 2026 11:19
- RBC Capital Maintains Sector Perform on BioMarin Pharmaceutical, Lowers Price Target to $60 (opens in a new tab) Benzinga · 03 Nov 2026 10:55
- Stifel Maintains Hold on BioMarin Pharmaceutical, Lowers Price Target to $66 (opens in a new tab) Benzinga · 03 Nov 2026 09:00
- BioMarin (BMRN) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 03 Nov 2026 04:43
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 56.70 USD
- Market cap
- 11.0B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow BMRN and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.